Sepsis Diagnostics Market By Product (Instruments, Blood Culture Media, Assay Kits & Reagents and Software) By Technology (Microbiology, Molecular Diagnostics, Immunoassays, Biomarkers and Others) By Pathogen (Bacterial, Fungal and Others) By End Users (Pathology Laboratories, Hospitals, Research Laboratories & Academic Institutes and Others), and By Region - Trends, Analysis, and Forecast till 2029

Market for sepsis diagnostics was valued at US$ 530.5 million in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 8.1% to reach US$ 1070 million by 2029.

When the body's overreaction to an infection damages its tissues and organs, it can lead to sepsis, a kind of severe, potentially fatal organ dysfunction. A bacterial, fungal, parasitic, or viral infection triggers the body to produce sepsis, which can result in multiple organ failure, septic shock, or even death. The World Health Organization estimates that sepsis kills 11 million people annually, many of them are children. Furthermore, among children, diarrheal illnesses, lower respiratory infections, and neonatal disorders were the most frequent causes of sepsis-related deaths. Sepsis is becoming more common, and with it, the mortality rate is rising.